Koos Boeve

29 General introduction and scope of this thesis malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. Gene 1995 Jun 14;159(1):83-96. 48. Ramos-Garcia P, Ruiz-Avila I, Gil- Montoya JA, Ayen A, Gonzalez-Ruiz L, Navarro-Trivino FJ, et al. Relevance of chromosomal band 11q13 in oral carcinogenesis: An update of current knowledge. Oral Oncol 2017 Sep;72:7-16. 49. Ramos-Garcia P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, Ruiz-Avila I, Gil-Montoya JA. Prognostic and clinicopathological significance of CTTN/ cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Head Neck 2019 Jun;41(6):1963-1978. 50. Ramos-Garcia P, Gonzalez-Moles MA, Gonzalez-Ruiz L, Ruiz-Avila I, Ayen A, Gil-Montoya JA. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta- analysis. Oral Oncol 2018 Aug;83:96-106. 51. Ramos-Garcia P, Gonzalez-Moles MA, Gonzalez-Ruiz L, Ayen A, Ruiz-Avila I, Navarro-Trivino FJ, et al. An update of knowledge on cortactin as a metastatic driver and potential therapeutic target in oral squamous cell carcinoma. Oral Dis 2019 May;25(4):949-971. 52. van Rossum AG, de Graaf JH, Schuuring- Scholtes E, Kluin PM, Fan YX, Zhan X, et al. Alternative splicing of the actin binding domain of human cortactin affects cell migration. J Biol Chem 2003 Nov 14;278(46):45672-45679. 53. Noorlag R, van Kempen PM, Stegeman I, Koole R, van Es RJ, Willems SM. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis. Virchows Arch 2015 Apr;466(4):363-373. 54. Ramos-Garcia P, Gil-Montoya JA, Scully C, Ayen A, Gonzalez-Ruiz L, Navarro-Trivino FJ, et al. An update on the implications of cyclin D1 in oral carcinogenesis. Oral Dis 2017 Oct;23(7):897-912. 55. Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, et al. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck. Histopathology 2013 Aug;63(2):263- 270. 56. van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, et al. Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol 2012 Nov 20;30(33):4104-4110. 57. Mes SW, Te Beest D, Poli T, Rossi S, Scheckenbach K, van Wieringen WN, et al. Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables. Oncotarget 2017 Jul 26;8(35):59312-59323. 58. Roepman P, Kemmeren P, Wessels LF, Slootweg PJ, Holstege FC. Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res 2006 Feb 15;66(4):2361-2366. 59. Mes SW, Leemans CR, Brakenhoff RH. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art. Expert Rev Mol Diagn 2016;16(2):205-221. 60. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, et al. Molecular